# A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder

> **NCT02288325** · PHASE4 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 644 (actual)

## Conditions studied

- Depressive Disorder, Major

## Interventions

- **DRUG:** Levomilnacipran ER
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02288325
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-18
- **Primary completion:** 2016-09-16
- **Final completion:** 2016-09-16
- **Target enrollment:** 644 (ACTUAL)
- **Last updated:** 2018-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02288325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02288325, "A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02288325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*